Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following is a summary of cash, cash equivalents and restricted cash on the consolidated balance sheets (in thousands):

	December 31, 2025		December 31, 2024
Cash	$	28,983	$	32,251
U.S. Treasury	16,434		4,743
Money market funds	45,436		61,722
Restricted cash	—		29
Total cash, cash equivalents and restricted cash as presented on the consolidated statements of cash flows	$	90,853	$	98,745

Restrictions on Cash and Cash Equivalents

The following is a summary of cash, cash equivalents and restricted cash on the consolidated balance sheets (in thousands):

	December 31, 2025		December 31, 2024
Cash	$	28,983	$	32,251
U.S. Treasury	16,434		4,743
Money market funds	45,436		61,722
Restricted cash	—		29
Total cash, cash equivalents and restricted cash as presented on the consolidated statements of cash flows	$	90,853	$	98,745

Schedule of Accounts Receivable, Allowance for Doubtful Debt

The changes in the allowance for credit losses for the year ended December 31, 2025 were as follows (in thousands):

Allowance for credit losses
Balance at December 31, 2023	372
Utilization of allowance for credit losses	(197)
Provision for credit losses	135
Balance at December 31, 2024	$	310
Utilization of allowance for credit losses	—
Provision for credit losses	419
Balance at December 31, 2025	$	729

Schedule of Useful Life of Property Plant and Equipment

The Company’s estimated useful lives of its property and equipment are as follows:

	Estimated Useful Lives
Building	20 years
Furniture and fixtures	5 - 7 years
Laboratory equipment	5 - 10 years
Office and computer equipment	3 - 5 years
Leasehold improvements	Shorter of expected lease term or estimated useful life

Schedule of Finite-Lived Intangible Assets

The Company’s estimated useful lives of its intangible assets are as follows:

	Estimated Useful Lives
Patent	20 years
Trademarks	10 years
Trade name	2 - 15 years
FCI developed technology	1 - 6 years
Customer relationship	7 - 9 years
Reagent licenses	7 years
IP license	5 years